A detailed history of Jpmorgan Chase & CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 785,295 shares of TVTX stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
785,295
Previous 349,160 124.91%
Holding current value
$14.2 Million
Previous $2.69 Million 139.78%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.26 - $8.28 $2.29 Million - $3.61 Million
436,135 Added 124.91%
785,295 $6.46 Million
Q1 2024

May 10, 2024

SELL
$7.18 - $9.82 $305,552 - $417,899
-42,556 Reduced 10.86%
349,160 $2.69 Million
Q4 2023

Feb 12, 2024

SELL
$5.44 - $9.5 $500,452 - $873,952
-91,995 Reduced 19.02%
391,716 $3.52 Million
Q3 2023

Nov 14, 2023

SELL
$7.64 - $17.25 $1.88 Million - $4.24 Million
-245,697 Reduced 33.68%
483,711 $4.32 Million
Q2 2023

Aug 11, 2023

SELL
$15.3 - $22.61 $6.19 Million - $9.15 Million
-404,743 Reduced 35.69%
729,408 $11.2 Million
Q1 2023

May 18, 2023

BUY
$17.82 - $22.89 $1.4 Million - $1.79 Million
78,362 Added 7.42%
1,134,151 $25.5 Million
Q1 2023

May 11, 2023

SELL
$17.82 - $22.89 $2.98 Million - $3.83 Million
-167,169 Reduced 13.67%
1,055,789 $23.7 Million
Q4 2022

Feb 13, 2023

BUY
$18.47 - $26.14 $3.07 Million - $4.34 Million
165,955 Added 15.7%
1,222,958 $25.7 Million
Q3 2022

Nov 14, 2022

SELL
$22.91 - $28.63 $937,797 - $1.17 Million
-40,934 Reduced 3.73%
1,057,003 $26 Million
Q2 2022

Aug 11, 2022

BUY
$20.94 - $30.01 $279,946 - $401,203
13,369 Added 1.23%
1,097,937 $26.6 Million
Q1 2022

May 11, 2022

SELL
$23.61 - $30.6 $1.18 Million - $1.53 Million
-49,941 Reduced 4.4%
1,084,568 $27.9 Million
Q4 2021

Feb 10, 2022

BUY
$24.34 - $31.17 $3.85 Million - $4.94 Million
158,369 Added 16.22%
1,134,509 $35.2 Million
Q3 2021

Nov 12, 2021

BUY
$12.98 - $25.03 $12.7 Million - $24.4 Million
976,140 New
976,140 $23.7 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.16B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.